Therapy Areas: Infectious Diseases
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
7 November 2025 - PharmaJet®, a leader in needle-free drug delivery systems designed to improve outcomes and patient comfort, has confirmed a new Distribution Agreement with ATR, an affiliate comp...
Oxford Nanopore and bioMérieux introduce AmPORE-TB for rapid tuberculosis resistance characterisation
5 November 2025 - French diagnostics company bioMérieux (Euronext Paris:BIM) and UK-based molecular sensing technology company Oxford Nanopore Technologies (LON:ONT) on Wednesday announced the ...
4basebio synthetic DNA used in Phase I/II mRNA therapy trial
27 October 2025 -

Biotechnology company 4basebio PLC (AIM: 4BB) announced on Monday that a global Tier 1 pharmaceutical partner has commenced dosing...

Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
...
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
21 October 2025 - Cumberland Pharmaceuticals Inc (Nasdaq:CPIX), a US-based specialty pharmaceutical company, announced on Monday that it has entered into strategic arrangements with RedHill Biopharma ...
Merck KGaA to acquire JSR Life Sciences chromatography business to expand Protein A capabilities
15 October 2025 - German science and technology company Merck KGaA (ETR:MRK) announced on Wednesday that its Life Science business, which operates as MilliporeSigma in the US and Canada, has signed a ...